Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders.

Mofazzal Jahromi MA, Abdoli A, Rahmanian M, Bardania H, Bayandori M, Moosavi Basri SM, Kalbasi A, Aref AR, Karimi M, Hamblin MR.

Mol Neurobiol. 2019 Jul 1. doi: 10.1007/s12035-019-01653-2. [Epub ahead of print] Review.

PMID:
31264092
2.

Aggregate Forms of Recombinant Human Erythropoietin With Different Charge Profile Substantially Impact Biological Activities.

Ghezlou M, Mokhtari F, Kalbasi A, Riazi G, Kaghazian H, Emadi R, Aref AR.

J Pharm Sci. 2019 Jun 16. pii: S0022-3549(19)30375-2. doi: 10.1016/j.xphs.2019.05.036. [Epub ahead of print]

PMID:
31216452
3.

Personalized medicine in breast cancer: pharmacogenomics approaches.

Jeibouei S, Akbari ME, Kalbasi A, Aref AR, Ajoudanian M, Rezvani A, Zali H.

Pharmgenomics Pers Med. 2019 May 27;12:59-73. doi: 10.2147/PGPM.S167886. eCollection 2019. Review.

4.

Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy.

Rice SR, Saboury B, Houshmand S, Salavati A, Kalbasi A, Goodman CR, Werner TJ, Vujaskovic Z, Simone CB 2nd, Alavi A.

Nucl Med Commun. 2019 Jun;40(6):618-625. doi: 10.1097/MNM.0000000000000997.

PMID:
31095527
5.

Interleukin 32 expression in human melanoma.

Paz H, Tsoi J, Kalbasi A, Grasso CS, McBride WH, Schaue D, Butterfield LH, Maurer DM, Ribas A, Graeber TG, Economou JS.

J Transl Med. 2019 Apr 5;17(1):113. doi: 10.1186/s12967-019-1862-y.

6.

Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.

Shurell-Linehan E, DiPardo BJ, Elliott IA, Graham DS, Eckardt MA, Dry SM, Nelson SD, Singh AS, Kalbasi A, Federman N, Bernthal NM, Eilber FC.

Am J Clin Oncol. 2019 May;42(5):426-431. doi: 10.1097/COC.0000000000000536.

PMID:
30913092
7.

A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.

Nowicki TS, Berent-Maoz B, Cheung-Lau G, Huang RR, Wang X, Tsoi J, Kaplan-Lefko P, Cabrera P, Tran J, Pang J, Macabali M, Garcilazo IP, Carretero IB, Kalbasi A, Cochran AJ, Grasso CS, Hu-Lieskovan S, Chmielowski B, Comin-Anduix B, Singh A, Ribas A.

Clin Cancer Res. 2019 Apr 1;25(7):2096-2108. doi: 10.1158/1078-0432.CCR-18-3496. Epub 2018 Dec 20.

PMID:
30573690
8.

SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study.

Ribas A, Medina T, Kummar S, Amin A, Kalbasi A, Drabick JJ, Barve M, Daniels GA, Wong DJ, Schmidt EV, Candia AF, Coffman RL, Leung ACF, Janssen RS.

Cancer Discov. 2018 Oct;8(10):1250-1257. doi: 10.1158/2159-8290.CD-18-0280. Epub 2018 Aug 28.

PMID:
30154193
9.

Optical assays based on colloidal inorganic nanoparticles.

Ghasemi A, Rabiee N, Ahmadi S, Hashemzadeh S, Lolasi F, Bozorgomid M, Kalbasi A, Nasseri B, Shiralizadeh Dezfuli A, Aref AR, Karimi M, Hamblin MR.

Analyst. 2018 Jul 21;143(14):3249-3283. doi: 10.1039/c8an00731d. Epub 2018 Jun 20. Review.

PMID:
29924108
10.

Point-of-care microfluidic devices for pathogen detection.

Nasseri B, Soleimani N, Rabiee N, Kalbasi A, Karimi M, Hamblin MR.

Biosens Bioelectron. 2018 Oct 15;117:112-128. doi: 10.1016/j.bios.2018.05.050. Epub 2018 May 29. Review.

PMID:
29890393
11.

Antigen Presentation Keeps Trending in Immunotherapy Resistance.

Kalbasi A, Ribas A.

Clin Cancer Res. 2018 Jul 15;24(14):3239-3241. doi: 10.1158/1078-0432.CCR-18-0698. Epub 2018 Apr 19.

12.

Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.

Pennington JD, Eilber FC, Eilber FR, Singh AS, Reed JP, Chmielowski B, Eckardt JJ, Bukata SV, Bernthal NM, Federman N, Nelson SD, Dry SM, Wang PC, Luu M, Selch MT, Steinberg ML, Kalbasi A, Kamrava M.

Am J Clin Oncol. 2018 Dec;41(12):1154-1161. doi: 10.1097/COC.0000000000000443.

PMID:
29664796
13.

Inappropriate Management of Asymptomatic Patients With Positive Urine Cultures: A Systematic Review and Meta-analysis.

Flokas ME, Andreatos N, Alevizakos M, Kalbasi A, Onur P, Mylonakis E.

Open Forum Infect Dis. 2017 Nov 20;4(4):ofx207. doi: 10.1093/ofid/ofx207. eCollection 2017 Fall.

14.

Proton craniospinal irradiation during the third trimester of pregnancy.

Kalbasi A, Kirk M, Teo BK, Diffenderfer E, Ding X, McDonough J, Murphy E, Hill-Kayser C.

Pract Radiat Oncol. 2018 May - Jun;8(3):213-216. doi: 10.1016/j.prro.2017.09.005. Epub 2017 Sep 18. No abstract available.

PMID:
29066161
15.

Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis/autoimmune sclerosing cholangitis.

Liberal R, Grant CR, Yuksel M, Graham J, Kalbasi A, Ma Y, Heneghan MA, Mieli-Vergani G, Vergani D, Longhi MS.

Hepatology. 2017 Nov;66(5):1570-1584. doi: 10.1002/hep.29307. Epub 2017 Oct 3.

16.

Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma.

Kalbasi A, Rengan R.

Transl Lung Cancer Res. 2017 Apr;6(2):169-177. doi: 10.21037/tlcr.2017.03.03. Review.

17.

Bilirubin suppresses Th17 immunity in colitis by upregulating CD39.

Longhi MS, Vuerich M, Kalbasi A, Kenison JE, Yeste A, Csizmadia E, Vaughn B, Feldbrugge L, Mitsuhashi S, Wegiel B, Otterbein L, Moss A, Quintana FJ, Robson SC.

JCI Insight. 2017 May 4;2(9). pii: 92791. doi: 10.1172/jci.insight.92791. eCollection 2017 May 4.

18.

Functio Laesa: Cancer Inflammation and Therapeutic Resistance.

Liu M, Kalbasi A, Beatty GL.

J Oncol Pract. 2017 Mar;13(3):173-180. doi: 10.1200/JOP.2016.020347. Review. Erratum in: J Oncol Pract. 2017 Jul;13(7):466.

19.

Clinical Factors That Affect the Establishment of Soft Tissue Sarcoma Patient-Derived Orthotopic Xenografts: A University of California, Los Angeles, Sarcoma Program Prospective Clinical Trial.

Russell TA, Eckardt MA, Murakami T, Elliott IA, Kawaguchi K, Kiyuna T, Igarashi K, Li Y, Crompton JG, Graham DS, Dry SM, Bernthal N, Yanagawa J, Kalbasi A, Federman N, Chmielowski B, Singh AS, Hoffman RM, Eilber FC.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.17.00071. Epub 2017 Aug 4.

20.

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.

Shin DS, Zaretsky JM, Escuin-Ordinas H, Garcia-Diaz A, Hu-Lieskovan S, Kalbasi A, Grasso CS, Hugo W, Sandoval S, Torrejon DY, Palaskas N, Rodriguez GA, Parisi G, Azhdam A, Chmielowski B, Cherry G, Seja E, Berent-Maoz B, Shintaku IP, Le DT, Pardoll DM, Diaz LA Jr, Tumeh PC, Graeber TG, Lo RS, Comin-Anduix B, Ribas A.

Cancer Discov. 2017 Feb;7(2):188-201. doi: 10.1158/2159-8290.CD-16-1223. Epub 2016 Nov 30.

21.

Expanding Tumor Lymphocytic Infiltration as a Prognostic Tool to Patients with NSCLC Who Are Treated with Radiotherapy?

Kalbasi A, Beatty GL, Berman AT.

J Thorac Oncol. 2016 Nov;11(11):e141-e142. doi: 10.1016/j.jtho.2016.07.029. No abstract available.

22.

Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.

Kalbasi A, Komar C, Tooker GM, Liu M, Lee JW, Gladney WL, Ben-Josef E, Beatty GL.

Clin Cancer Res. 2017 Jan 1;23(1):137-148. doi: 10.1158/1078-0432.CCR-16-0870. Epub 2016 Jun 28.

23.

PET-Based Thoracic Radiation Oncology.

Simone CB 2nd, Houshmand S, Kalbasi A, Salavati A, Alavi A.

PET Clin. 2016 Jul;11(3):319-32. doi: 10.1016/j.cpet.2016.03.001. Epub 2016 Apr 6. Review.

PMID:
27321035
24.

Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs.

Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4840-52. doi: 10.1128/AAC.00825-16. Print 2016 Aug.

25.

Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer.

Kalbasi A, Li J, Berman A, Swisher-McClure S, Smaldone M, Uzzo RG, Small DS, Mitra N, Bekelman JE.

JAMA Oncol. 2015 Oct;1(7):897-906. doi: 10.1001/jamaoncol.2015.2316.

PMID:
26181727
26.

99mTc-phytate as a diagnostic probe for assessing inflammatory reaction in malignant tumors.

Fernandes RS, Mota LG, Kalbasi A, Moghbel M, Werner TJ, Alavi A, Rubello D, Cardoso VN, de Barros AL.

Nucl Med Commun. 2015 Oct;36(10):1042-8. doi: 10.1097/MNM.0000000000000358.

PMID:
26147941
27.

Effects of storage time on compositional, micro-structural, rheological and sensory properties of low fat Iranian UF-Feta cheese fortified with fish oil or fish oil powder.

Farbod F, Kalbasi A, Moini S, Emam-Djomeh Z, Razavi H, Mortazavi A.

J Food Sci Technol. 2015 Mar;52(3):1372-82. doi: 10.1007/s13197-013-1163-z. Epub 2013 Sep 12.

28.

Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features.

Kalbasi A, Swisher-McClure S, Mitra N, Sunderland R, Smaldone MC, Uzzo RG, Bekelman JE.

Cancer. 2014 Oct 1;120(19):3089-96. doi: 10.1002/cncr.28856. Epub 2014 Jun 10.

29.

Radiation and immunotherapy: a synergistic combination.

Kalbasi A, June CH, Haas N, Vapiwala N.

J Clin Invest. 2013 Jul;123(7):2756-63. doi: 10.1172/JCI69219. Epub 2013 Jul 1.

30.

A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant cases.

Xie C, Kim HJ, Haw JG, Kalbasi A, Gardner BK, Li G, Rao J, Chia D, Liong M, Punzalan RR, Marks LS, Pantuck AJ, de la Taille A, Wang G, Mukouyama H, Zeng G.

J Transl Med. 2011 Apr 19;9:43. doi: 10.1186/1479-5876-9-43.

31.

CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893.

Kalbasi A, Fonsatti E, Natali PG, Altomonte M, Bertocci E, Cutaia O, Calabrò L, Chiou M, Tap W, Chmielowski B, Maio M, Ribas A.

J Immunother. 2010 Oct;33(8):810-6. doi: 10.1097/CJI.0b013e3181ee73a7.

PMID:
20842056
32.
33.

Fractionation of monomeric and polymeric anthocyainins from Concord grape (Vitis labrusca L.) juice by membrane ultrafiltration.

Kalbasi A, Cisneros-Zevallos L.

J Agric Food Chem. 2007 Aug 22;55(17):7036-42. Epub 2007 Aug 1.

PMID:
17665929

Supplemental Content

Loading ...
Support Center